These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4550365)

  • 21. FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration.
    James JS
    AIDS Treat News; 1998 Mar; (No 290):8. PubMed ID: 11365123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressants: old drugs, new uses.
    Harris E
    Am J Nurs; 1981 Jul; 81(7):1308-9. PubMed ID: 6910335
    [No Abstract]   [Full Text] [Related]  

  • 23. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 24. Investigational new drug, antibiotic, and biological product applications; clinical hold and termination--FDA. Final rule.
    Fed Regist; 1992 Apr; 57(73):13244-9. PubMed ID: 10118458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introductory remarks: new agents in psychiatry.
    Vinar O
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):743-4. PubMed ID: 4201969
    [No Abstract]   [Full Text] [Related]  

  • 26. [First-in-human clinical trials: comparison of EMEA and FDA guidelines].
    Hernández-López C
    Med Clin (Barc); 2009 Jan; 132(1):30-4. PubMed ID: 19174063
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical trial of a new drug, analog of chlordiazepoxide, for treatment of anxiety and tension.
    Gilbert MM
    Int J Neuropsychiatry; 1965 Dec; 1(6):556-8. PubMed ID: 5886535
    [No Abstract]   [Full Text] [Related]  

  • 28. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
    Schultheis LW; Rappaport BA
    Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
    [No Abstract]   [Full Text] [Related]  

  • 29. Investigational new drugs submitted to the Food and Drug Administration that are placed on clinical hold: the experience of the Office of Cellular, Tissue and Gene Therapy.
    Wonnacott K; Lavoie D; Fiorentino R; McIntyre M; Huang Y; Hirschfeld S
    Cytotherapy; 2008; 10(3):312-6. PubMed ID: 18418776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [4 years of experience with dipotassium chlorazepate].
    Miletto G
    Ann Med Psychol (Paris); 1969 Mar; 1(3):468-73. PubMed ID: 5376740
    [No Abstract]   [Full Text] [Related]  

  • 31. US drug trials said to ignore gender differences.
    Watson T
    Nature; 1992 Nov; 360(6399):6. PubMed ID: 1436074
    [No Abstract]   [Full Text] [Related]  

  • 32. New FDA rules force drug makers to detail youth-specific effects. Food and Drug Administration.
    Newsline People AIDS Coalit N Y; 1999 Jan; ():34. PubMed ID: 11367188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptom-reduction trials at FDA clinical trials workshop. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Sep; (no 231):7. PubMed ID: 11362873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How experimental drugs are tested in humans.
    Flieger K
    Pediatr Infect Dis J; 1989 Mar; 8(3):160-2. PubMed ID: 2710587
    [No Abstract]   [Full Text] [Related]  

  • 35. Criteria supporting the study of drugs in the newborn.
    Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A
    Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA evaluates accelerated approval process. Food and Drug Administration.
    Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspectives on the U.S. FDA Bioresearch Monitoring Program.
    Gamet JE
    Qual Assur; 1995 Mar; 4(1):12-9. PubMed ID: 8520859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. General practitioner clinical trials. Two new psychotropic drugs.
    Practitioner; 1967 Jan; 198(183):135-41. PubMed ID: 5341297
    [No Abstract]   [Full Text] [Related]  

  • 39. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New office and new leader aim to streamline FDA cancer drug review process.
    Twombly R
    J Natl Cancer Inst; 2005 May; 97(10):708-9. PubMed ID: 15900036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.